There was no committee of academic and statistical experts to review the results. Instead, a meeting was held between the pharmaceutical companies and the FDA, and legacy data, preceding the Delta outbreak was reviewed giving the meeting participants a knowingly false impression of high vaccine efficacy which clearly has been lost as the SARS-CoV-2 had mutated...